Aortic Prosthetic Valve Endocarditis: Analysis of The Society of Thoracic Surgeons Database
AuthorPolo, Manuel Caceres
Jawitz, Oliver K
Zwischenberger, Brittany A
O'Brien, Sean M
Thourani, Vinod H
Jacobs, Jeffrey P
Hooker, Robert L
AffiliationDepartment of Surgery, University of Arizona
MetadataShow full item record
CitationPolo, M. C., Thibault, D., Jawitz, O. K., Zwischenberger, B. A., O’Brien, S. M., Thourani, V. H., Jacobs, J. P., & Hooker, R. L. (2022). Aortic Prosthetic Valve Endocarditis: Analysis of The Society of Thoracic Surgeons Database. Annals of Thoracic Surgery.
JournalThe Annals of thoracic surgery
RightsCopyright © 2022 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractBackground: This study sought to characterize the current US experience of aortic prosthetic valve endocarditis (PVE) compared with native valve endocarditis (NVE). Methods: The Society of Thoracic Surgeons Database was queried for entries of active aortic infective endocarditis (IE). Two analyses were performed: (1) trends of surgical volume and operative mortality (2011-2019); and (2) descriptive and risk-adjusted comparisons between PVE and NVE (2014-2019) using multivariable logistic regression. Results: From 2011 to 2019, there was a yearly increase in the proportion of PVE (20.9% to 25.9%; P <.001) with a concurrent decrease in operative mortality (PVE, 22.5% to 10.4%; P <.001; NVE, 10.9% to 8.5%; P <.001). From 2014 to 2019, active aortic IE was identified in 9768 patients (NVE, 6842; PVE, 2926). Aortic root abscess (50.1% vs 25.2%; P <.001), aortic root replacement (50.1% vs 12.8%; P <.001), homograft implantation (27.2% vs 4.1%; P <.001), and operative mortality (12.2% vs 6.4%; P <.001) were higher in PVE. After risk adjustment, PVE (odds ratio [OR], 1.5; 95% CI,1.16-1.94; P <.01), aortic root replacement (OR, 1.49; 95% CI,1.15-1.92; P <.001), Staphylococcus aureus (OR, 1.5; 95% CI,1.23-1.82; P <.001), and unplanned revascularization (OR, 5.83; 95% CI,4.12-8.23; P <.001) or mitral valve surgery (OR, 2.29; 95% CI,1.5-3.51; P <.001) correlated with a higher operative mortality, whereas prosthesis type (P =.68) was not an independent predictor. Conclusions: IE in the United States has risen over the past decade. However, operative mortality has decreased for both PVE and NVE. PVE, extension of IE requiring aortic root replacement, and additional unplanned surgical interventions carry an elevated mortality risk. Prosthesis selection did not affect operative mortality.
Note12 month embargo; published: 04 December 2021
VersionFinal accepted manuscript
- Immediate and long-term results of valve replacement for native and prosthetic valve endocarditis.
- Authors: Delay D, Pellerin M, Carrier M, Marchand R, Auger P, Perrault LP, Hébert Y, Cartier R, Pagé P, Pelletier LC
- Issue date: 2000 Oct
- Surgery for infective endocarditis: determinate factors in the outcome.
- Authors: Ishikawa S, Kawasaki A, Neya K, Abe K, Suzuki H, Kadowaki S, Nakamura K, Ueda K
- Issue date: 2008 Aug
- Higher incidence of perivalvular abscess determines perioperative clinical outcome in patients undergoing surgery for prosthetic valve endocarditis.
- Authors: Weber C, Rahmanian PB, Nitsche M, Gassa A, Eghbalzadeh K, Hamacher S, Merkle J, Deppe AC, Sabashnikov A, Kuhn EW, Liakopoulos OJ, Wahlers T
- Issue date: 2020 Feb 3
- Early outcome after surgery for active native and prosthetic aortic valve endocarditis.
- Authors: Gabbieri D, Dohmen PM, Linneweber J, Grubitzsch H, von Heymann C, Neumann K, Halle E, Konertz WF
- Issue date: 2008 Sep
- Residual patient, anatomic, and surgical obstacles in treating active left-sided infective endocarditis.
- Authors: Hussain ST, Shrestha NK, Gordon SM, Houghtaling PL, Blackstone EH, Pettersson GB
- Issue date: 2014 Sep